Delivery Order SPE2DB20D7059-SPE2DB25FPXK2
Award Date
1/6/25
Potential Completion Date
1/7/25
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,417.20 and is a Firm Fixed Price Delivery Order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a period of performance through December 20, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999...
This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,508.03, was awarded to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 31, 2024 and is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a...
This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,800.41 Firm Fixed Price delivery order was awarded on December 19, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 20, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, as a delivery order under a broader Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to supply a comprehensive range of pharmaceutical products and...
This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $19,230.15. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 27, 2024. This contract is part of a larger Indefinite...
This federal contract award is for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,322.76 and an ultimate completion date of December 16, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,318.56, was awarded to Amerisourcebergen Drug Corp, a for-profit subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. This contract is a firm fixed price delivery order and does not have a set-aside designation.
Amerisourcebergen Drug Corp holds an Indefinite Delivery...
This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world.
The contract has a ceiling value of $39,339.30 and is a firm fixed price delivery order with a completion date of May 2, 2024. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a delivery order. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 25, 2023, with a ceiling value of $23,275.35 and a completion date of September 26, 2023.
The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award is for the delivery of GEMTESA 75 MG TABLET 30S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract has a ceiling value of $8,637.15 and an ultimate completion date of April 30, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government, including the Department of Defense (DoD) and Department of Veterans...